United KingdomRene Haas, CEO of Arm Holdings, the UK's largest tech firm, stated that artificial intelligence will eventually discover a cure for cancer that humans cannot achieve in their lifetimes. He explained that modeling the impact of cancer on DNA markers is currently too complex for both humans and existing computers, but AI-powered systems will overcome this challenge in the future. Haas noted that the development of AI is being hindered by a global shortage of microchips required for data centers. While he predicted the rise of humanoid robots powered by AI in various industries within five years, he expressed skepticism about the feasibility of manufacturing such chips in the UK. Arm's technology is embedded in billions of devices worldwide, and the company reached its highest valuation during the AI boom earlier this year. Prof Chris Bakal emphasized that the success of medical AI depends less on computational power and more on the quality of data fed into the systems, suggesting that AI could significantly accelerate treatment development.
Bias read (Center): The article discusses technological advancements and predictions related to AI and microchip design, focusing on scientific and industrial developments rather than political issues. There is no clear ideological framing or bias in the content.
